In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 94 for your search:
Drug:  vorinostat
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: COG-ACNS0822, ACNS0822, NCT01236560
2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MK-0683-014, 2005_010, NCT00128102
3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-06-C-0040, MERCK-014-01, NCI-P6690, NCT00265577, UCLA-0506053-01, MERCK-014-00
4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MK-0683-088, 2008_525, NCT00773747
5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000449963, U10CA021115, ECOG-E1104, E1104, NCT00258349
6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000467800, R21CA121590, P30CA006973, JHOC-J0570, JHOC-00001107, NCI-6884, J0570, 6884, NCT00324870
7.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000495242, AECM-0605291, NCI-7703, 06-05-291, 7703, NCT00368875
8.

Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NYCC-6898, 6898, NCI-6898, NCT00392353
9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: BR05/24/06, DSRB Reference Code: B/06/275, HSA No: CTC0600314, NCT00416130
10.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: PSOC 2302, NCI-2010-00870, 6632, FHCRC-IR-6632, NCT00601718
11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: 08-045, NCT00667615
12.

Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N0874, NCCTG N0874, N0874, ABTC 0902, NCT00731731
13.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GFM VOR 2007-01, NCT00776503
14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 00016446, NCT00939991
15.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-114, NCT00948688
16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2004_029, MK0683-013, NCT00097929
17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0412112-01, MERCK-CL-01-0303 (2), NCT00091559, MERCK-001-02
18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000436851, PMH-PHL-040, NCI-6916, 6916, NCT00121225
19.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0411065-01, MERCK-013-00, NCT00124631
20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000438779, U10CA032102, S0517, SWOG-S0517, NCT00132028
21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-04110, 6902, NCI-6902, NCT00134043
22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-0170H, NCT00132067
23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: J0504 CDR0000445404, U01CA070095, P30CA006973, JHOC-J0504, NCI-6914, J0504, 6914, NCT00262834
24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00646, N047B, U10CA025224, CDR0000445405, NCCTG-N047B, NCT00238303
25.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000449981, P30CA033572, CCC-PHII-63, NCI-6963, 6963, NCT00253630
1     
New Search